Catawba Capital Management’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-7,657
Closed -$783K 261
2014
Q4
$783K Hold
7,657
0.18% 115
2014
Q3
$662K Sell
7,657
-600
-7% -$53.1K 0.15% 135
2014
Q2
$745K Sell
8,257
-35
-0.4% -$2.62K 0.17% 127
2014
Q1
$611K Hold
8,292
0.15% 140
2013
Q4
$565K Sell
8,292
-64
-0.8% -$4.16K 0.14% 144
2013
Q3
$509K Sell
8,356
-1,154
-12% -$70.4K 0.13% 149
2013
Q2
$530K Buy
+9,510
New +$550K 0.15% 138

Catawba Capital Management's COV Position: Q1 2015 in Review

Catawba Capital Management sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 7,657 shares — an estimated $783K sold.

Catawba Capital Management first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $783K in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Catawba Capital Management reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Catawba Capital Management sold 7,657 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $783K.
  • Catawba Capital Management first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Catawba Capital Management's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $783K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Catawba Capital Management's 13F filing for Q1 2015, filed 14 Apr 2015.